11/17/2025
“Meeting Patients Where They Are: Navigating Decision-Making Challenges During Office-Based Management of Opioid Use Disorder”
Presented by: Aaron Newcomb, DO
Buprenorphine treatment is evidence-based and lifesaving, yet clinicians regularly face complex scenarios that fall outside the scope of national guidelines and existing research. This presentation highlights common dilemmas in office-based opioid use disorder treatment and offers practical, patient-centered strategies for navigating uncertainty. Through real-world case examples, it explores decision-making around buprenorphine mono-product use, early refill requests, unexpected toxicology results, anonymous reports, and the co-prescribing of benzodiazepines or psychostimulants all while balancing compassionate care with regulatory considerations.
By the end of this session, participants will be able to recognize common clinical challenges in buprenorphine treatment that lack clear evidence or guidance, apply patient-centered and evidence-informed reasoning to ambiguous situations, understand how regulatory fears influence provider decision-making, and strengthen clinical judgment through case-based examples demonstrating nuanced, real-world approaches to care.
NAV & Associates is proud to support research and initiatives that advance addiction science and promote better outcomes for patients and communities.
